Treatment outcomes in palliative care: The TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Lowther, Keira ^a   Simms, Victoria ^b   Selman, Lucy ^a   Sherr, Lorraine ^c   Gwyther, Liz ^d   Kariuki, Hellen ^e   Ahmed, Aabid ^f   Ali, Zipporah ^g   Jenkins, Rachel ^a   Higginson, Irene J ^a   Harding, Richard ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f Bomu Medical Centre   (Kenya)

^g Kenyan Hospice Palliative Care Association   (Kenya)

Author keywords

Africa; ART; Evaluation; HIV; Palliative care

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN PALLIATIVE CARE ASSOCIATION AFRICAN PALLIATIVE OUTCOME SCALE; ANALGESIA; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; GENERAL HEALTH QUESTIONNAIRE; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; NULL HYPOTHESIS; NURSING PRACTICE; OUTPATIENT CARE; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PILOT STUDY; PSYCHOLOGICAL WELL BEING; QUALITATIVE RESEARCH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SELF REPORT; SEMI STRUCTURED INTERVIEW; SPIRITUAL CARE; STAFF NURSE; STANDARD; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME; TWO TAILED TEST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; BIOMEDICAL RESEARCH; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NURSES; PALLIATIVE CARE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868266770     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-288     Document Type: Article

References (62)

1. UNAIDS UNAIDS 2010 global report 2010, Geneva Switzerland: UNAIDS, UNAIDS.
2. Piot P, Coll Seck AM. International response to the HIV/AIDS epidemic: planning for success. Bull World Health Organ 2001, 79(12):1106-1112. 2566707, 11799442.
3. WHO Rapid advice. Antiretroviral therapy for HIV infection in adults and adolescents 2009, Geneva: WHO, WHO.
4. WHO Towards universal access scaling up priority HIV/AIDS interventions in the health sector: progress report 2010 2010, Geneva: WHO Press, WHO.
5. Campos LN, Cesar CC, Guimaraes MDC. Quality of life among HIV-infected patients in Brazil after initiation of treatment. Clinics (Sao Paulo) 2009, 64(9):867-875.
6. Fan APC, et al. Quality of life and needs assessment on people living with HIV and AIDS in Malawi. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV 2011, 23(3):287-302.
7. Willard S, et al. Does " asymptomatic" mean without symptoms for those living with HIV infection?. AIDS Care 2009, 21(3):322-328. 10.1080/09540120802183511, 19280409.
8. Harding R, et al. Is antiretroviral therapy associated with symptom prevalence and burden?. Int J STD AIDS 2006, 17(6):400-405. 10.1258/095646206777323409, 16734963.
9. Bhengu BR, et al. Symptoms experienced by HIV-infected Individuals on antiretroviral therapy in KwaZulu-Natal, South Africa. Appl Nurs Res 2011, 24(1):1-9. 10.1016/j.apnr.2009.01.001, 20974052.
10. Harding R, et al. Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse. Sex Transm Infect 2010, 86(7):520-524. 10.1136/sti.2009.038505, 20551235.
11. Braithwaite R, et al. Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV. Value Health 2008, 11(5):975-979. 10.1111/j.1524-4733.2007.00315.x, 3121315, 18225989.
12. de Menezes Padua CA, et al. Self-reported adverse reactions among patients initiating antiretroviral therapy in Brazil. Braz J Infect Dis 2007, 11(1):20-26.
13. Fellay J, et al. Prevalence of adverse events associated with potent antiretroviral treatment: swiss HIV cohort study. Lancet 2001, 358(9290):1322-1327. 10.1016/S0140-6736(01)06413-3, 11684213.
14. Johnson MO, et al. Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage 2005, 29(2):193-205. 10.1016/j.jpainsymman.2004.05.005, 15793937.
15. Johnson MO, Stallworth T, Neilands TB. The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART. AIDS Behav 2003, 7(2):109-117. 10.1023/A:1023938023005, 14586196.
16. Mannheimer SB, et al. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis 2008, 46(6):941-945. 10.1086/528859, 18279044.
17. McInerney P, Ncama B, Wantland D. Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nurs Health Sci 2008, 10(4):266-272. 10.1111/j.1442-2018.2008.00410.x, 19128302.
18. Gibbie T, et al. Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS. Sex Health 2007, 4(4):227-232. 10.1071/SH06062, 18082064.
19. Eriksson LE, Bratt GA, Nordstrom G. The two-year impact of first generation protease inhibitor based antiretroviral therapy (PI-ART) on health-related quality of life. Health Qual Life Outcomes 2005, 3(32):1-8. 545054, 15634354.
20. Collins K, Harding R. Improving HIV management in sub-Saharan Africa: how much palliative care is needed?. AIDS Care 2007, 19(10):1304-1306. 10.1080/09540120701402863, 18071975.
21. WHO WHO definition of palliative care 2011 04.04.2011]; Available from: http://www.who.int/hiv/topics/palliative/PalliativeCare/en/, WHO.
22. Davies E, Higginson IJ. The solid facts. Palliative Care 2004, Copenhagen: WHO Europe.
23. Selwyn PA, Forstein M. Overcoming the false dichotomy of curative vs palliative care for late-stage HIV/AIDS: " let me live the way I want to live, until I can't" JAMA 2003, 290(6):806-814. 10.1001/jama.290.6.806, 12915434.
24. Harding R, et al. Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence. Sex Transm Infect 2005, 81(1):5-14. 10.1136/sti.2004.010132, 1763726, 15681714.
25. Harding R. Palliative care in resource-poor settings: fallacies and misapprehensions. J Pain Symptom Manage 2008, 36(5):515-517. 10.1016/j.jpainsymman.2008.04.019, 18971076.
26. Gwyther L. Just palliative care? Integrated models of care. J Pain Symptom Manage 2008, 36(5):517-519. 10.1016/j.jpainsymman.2008.06.003, 18971077.
27. Selwyn PA. Palliative care and social justice. J Pain Symptom Manage 2008, 36(5):513-515. 10.1016/j.jpainsymman.2008.08.001, 18971075.
28. UNAIDS AIDS: palliative care. Technical update 2000, Geneva: UNAIDS, UNAIDS.
29. Stjernsward J, Foley KM, Ferris FD. The public health strategy for palliative care. J Pain Symptom Manage 2007, 33(5):486-493. 10.1016/j.jpainsymman.2007.02.016, 17482035.
30. Harding R, et al. Access and equity in HIV/AIDS palliative care: a review of the evidence and responses. Palliat Med 2005, 19(3):251-258. 10.1191/0269216305pm1005oa, 15920940.
31. Protopopescu C, et al. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. J Antimicrob Chemother 2009, 64(3):599-606. 10.1093/jac/dkp232, 19602563.
32. Gonzalez JS, et al. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes: JAIDS 2011, 58(2):181-187.
33. Ekstrand ML, et al. Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. Int Health 2011, 3(1):27-34. 10.1016/j.inhe.2010.11.003, 3079268, 21516199.
34. Simms VM, Higginson IJ, Harding R. What palliative care-related problems Do patients experience at HIV diagnosis? a systematic review of the evidence. J Pain Symptom Manage 2011, 42(5):734-753. 10.1016/j.jpainsymman.2011.02.014, 21620647.
35. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Pettigrew M. Developing and Evaluating Complex Interventions: The new Medical Research Council guidance. BMJ 2008, 337:a1655. 10.1136/bmj.a1655, 2769032, 18824488.
36. Gwyther L. HPCA clinical guidelines [pdf] 2006 2008 28.09.2012]; Available from: http://www.hospicepalliativecaresa.co.za/pdf/guidelinedocs/HPCAClinicalGuidelines.pdf.
37. APCA Standards for providing quality palliative care across africa 2011 29/08/2012]; Available from: http://www.africanpalliativecare.org/images/stories/pdf/APCA_Standards.pdf, APCA.
38. Harding R, et al. PEPFAR public health evaluation-care and support: phase 2 kenya, in PEPFAR public health evaluation - care and support. U. PEPFAR, measure evaluation 2010, London: PEPFAR Public Health evaluation - Care and Support.
39. Powell RA, et al. Development of the APCA african palliative outcome scale. J Pain Symptom Manage 2007, 33(2):229-232. 10.1016/j.jpainsymman.2006.10.008, 17280929.
40. Dumville JC, Torgerson DJ, Hewitt CE. Reporting attrition in randomised controlled trials. BMJ 2006, 332(7547):969-971. 10.1136/bmj.332.7547.969, 1444839, 16627519.
41. Moher D, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869. 10.1136/bmj.c869, 2844943, 20332511.
42. Gwatkin DR RS, Johnson K, Pande RP, Wagstaff A. Socioeconomic differences in health, nutrition, and population in ghana, in health nutrition and population 2003, Ghana: World Bank.
43. Hearn J, Higginson IJ. Evelopment and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative care core audit project advisory group. Qual Health Care 1999, 8(4):219-227. 10.1136/qshc.8.4.219, 2483665, 10847883.
44. Higginson IJ, Donaldson N. Relationship between three palliative care outcome scales. Health Qual Life Outcomes 2004, 2:68. 10.1186/1477-7525-2-68, 539243, 15566627.
45. Harding R, et al. Validation of a core outcome measure for palliative care in africa: the APCA african palliative outcome scale. Health Qual Life Outcomes 2010, 8:10. 10.1186/1477-7525-8-10, 2825183, 20100332.
46. Harding R, et al. Multi-centred mixed-methods PEPFAR HIV care & support public health evaluation: study protocol. BMC Publ Health 2010, 10:584.
47. Bowling A. Measuring disease 2001, Buckingham: Open University Press.
48. Harding R, et al. Intensity and correlates of multidimensional problems in HIV patients receiving integrated palliative care in sub-Saharan Africa. Sex Transm Infect 2012, Epub ahead of print.
49. Wu AW, et al. A health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infection. Med Care 1991, 29(8):786-798. 10.1097/00005650-199108000-00011, 1875745.
50. Mast TC, et al. Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care 2004, 16(1):81-94. 10.1080/09540120310001633994, 14660146.
51. Epino HM, et al. Reliability and construct validity of three health-related self-report scales in HIV-positive adults in rural Rwanda. AIDS Care 2012, Epub ahead of print.
52. Taylor TN, et al. Reliability and validity of two HIV/AIDS-specific quality of life instruments adapted for use in HIV-positive Zimbabweans. AIDS Care 2009, 21(5):598-607. 10.1080/09540120802302574, 19444668.
53. Stangl AL, et al. Measuring quality of life in rural uganda: reliability and validity of summary scores from the medical outcomes study HIV health survey (MOS-HIV). Qual Life Res 2011, 21(9):1655-1663.
54. Goldberg D, Williams P. A user's guide to the general health questionnaire 1991, Windsor: NFER Nelson.
55. Goldberg DP, et al. A comparison of two psychiatric screening tests. Br J Psychiatry 1976, 129:61-67. 10.1192/bjp.129.1.61, 938806.
56. Abubakar A, Fischer R. The factor structure of the 12-item general health questionnaire in a literate kenyan population. Stress Heal 2011, 28(3):248-254.
57. Sherr L, et al. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care 2010, 22(8):939-945. 10.1080/09540121.2010.482126, 20574863.
58. Gomes B, et al. Variations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study. BMC Cancer 2010, 10:400. 10.1186/1471-2407-10-400, 2919503, 20678203.
59. McCrone P. Capturing the costs of end-of-life care: comparisons of multiple sclerosis, Parkinson's disease, and dementia. J Pain Symptom Manage 2009, 38(1):62-67. 10.1016/j.jpainsymman.2009.04.006, 19615628.
60. Harding R, Selman L, Simms V, Penfold S, Agupio G, Dinat N, Downing J, Gwyther L, Ikin B, Mashao T, Mmoledi K, Sebuyira LM, Moll T, Mwangi-Powell F, Namisango E, Powell RA, Walkey F, Higginson IJ, Siegert R. How to analyse palliative care outcome data for patients in sub-Saharan Africa: an international multicentred factor analytic examination of the APCA African POS. J Pain Symptom Manage 2012, In press.
61. Pope CZS, Mays N. Analysing qualitative data. Br Med J 2000, 320:114-116.
62. Creswell JW, Miller DL. Determining validity in qualitative inquiry. Theory Into Practice 2000, 39(3):124-130.